Literature DB >> 8033136

Enhanced cytochrome P450 (Cyp1b1) expression, aryl hydrocarbon hydroxylase activity, cytotoxicity, and transformation of C3H 10T1/2 cells by dimethylbenz(a)anthracene in conditioned medium.

Z Shen1, R L Wells, M M Elkind.   

Abstract

The basal and benz(a)anthracene-induced aryl hydrocarbon hydroxylase activities of C3H 10T1/2 mouse embryo fibroblasts have been shown to vary with population growth. We report here that, in the case of dimethylbenz(a)anthracene, cytotoxicity and transformation (neoplastic/morphological transformation and focus formation) increased as a consequence of population growth and, at high cell densities, DNA adduct formation was elevated. Among the factors that may contribute to these changes, we have found that conditioning of the medium with population growth plays a significant role. Cells treated with medium conditioned by several days of cell growth supported increases in the dimethylbenz(a)anthracene induction of mRNA expression of a new mouse cytochrome P450 gene designated Cyp1b1, aryl hydrocarbon hydroxylase activity, cytotoxicity, and the frequency of neoplastic transformation. These results suggest a cause and effect relationship between the enhanced expression of Cyp1b1 due to medium conditioning and the enhanced expression of the cellular endpoints cytotoxicity and transformation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033136

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

Review 1.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

2.  The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

Authors:  G A Potter; L H Patterson; E Wanogho; P J Perry; P C Butler; T Ijaz; K C Ruparelia; J H Lamb; P B Farmer; L A Stanley; M D Burke
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.